相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A
Keziah Cook et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males A Meta-analytic Approach Using National Registries
Alfonso Iorio et al.
ANNALS OF INTERNAL MEDICINE (2019)
Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States
Abe Dunn et al.
HEALTH SERVICES RESEARCH (2018)
Impact of hemophilia B on quality of life in affected men, women, and caregiversAssessment of patient-reported outcomes in the B-HERO-S study
Tyler W. Buckner et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
The benefits of prophylaxis in patients with hemophilia B
Giancarlo Castaman
EXPERT REVIEW OF HEMATOLOGY (2018)
Changing the Paradigm in Hemophilia Care: Extended Half-Life Products (rFVIIIFc and rFIXFc)
Louis M. Aledort et al.
BLOOD (2018)
Gene therapy in hemophilia A: a cost-effectiveness analysis
Nicoletta Machin et al.
BLOOD ADVANCES (2018)
Self-reported prevalence, description and management of pain in adults with haemophilia: methods, demographics and results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
M. Witkop et al.
HAEMOPHILIA (2017)
Prophylaxis use among males with haemophilia B in the United States
M. Ullman et al.
HAEMOPHILIA (2017)
Economic Burden of Illness among Persons with Hemophilia B from HUGS Vb: Examining the Association of Severity and Treatment Regimens with Costs and Annual Bleed Rates
Christina X. Chen et al.
VALUE IN HEALTH (2017)
Pain and pain management in haemophilia
Guenter Auerswald et al.
BLOOD COAGULATION & FIBRINOLYSIS (2016)
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses Second Panel on Cost-Effectiveness in Health and Medicine
Gillian D. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Emerging and future therapies for hemophilia
Marcus E. Carr et al.
JOURNAL OF BLOOD MEDICINE (2015)
Costs and utilization of hemophilia A and B patients with and without inhibitors
Edward P. Armstrong et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Molecular approaches for improved clotting factors for hemophilia
Randal J. Kaufman et al.
BLOOD (2013)
Guidelines for the management of hemophilia
A. Srivastava et al.
HAEMOPHILIA (2013)
A national study of pain in the bleeding disorders community: a description of haemophilia pain
M. Witkop et al.
HAEMOPHILIA (2012)
Health care expenditures for Medicaid-covered males with haemophilia in the United States, 2008
S. Guh et al.
HAEMOPHILIA (2012)
Healthcare expenditures for males with haemophilia and employer-sponsored insurance in the United States, 2008
S. Guh et al.
HAEMOPHILIA (2012)
Management of joint bleeding in hemophilia
Mindy L. Simpson et al.
EXPERT REVIEW OF HEMATOLOGY (2012)
Assessment and management of pain in haemophilia patients
R. R. Riley et al.
HAEMOPHILIA (2011)
Burden of Disease Resulting from Hemophilia in the US
Azfar-e-Alam Siddiqi et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2010)
A survey of adherence to haemophilia therapy in six European countries: results and recommendations
P. De Moerloose et al.
HAEMOPHILIA (2008)
Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection
Thomas Tencer et al.
JOURNAL OF MANAGED CARE PHARMACY (2007)
Pain and functional limitations in patients with severe haemophilia
FR van Genderen et al.
HAEMOPHILIA (2006)
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
HD Quan et al.
MEDICAL CARE (2005)
Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome
K Fischer et al.
HAEMOPHILIA (2002)
分享论文
